Eplerenone improved hypokalemia in a patient with Gitelman's syndrome

Internal Medicine

Volumn 51, Issue 1, 2012, Pages 83-86

  Ito, Yukiko ^a   Yoshida, Masanori ^a   Nakayama, Mikihiro ^b   Tsutaya, Shoji ^c   Ogawa, Koichiro ^a   Maeda, Harumi ^a   Miyata, Misaki ^a   Oiso, Yutaka ^d  

^a Ekisaikai Hospital   (Japan)

^b Nakayama Clinic   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Eplerenone; Gitelman's syndrome; Hypokalemia; SLC12A3 gene

Indexed keywords

EPLERENONE; MAGNESIUM OXIDE; POTASSIUM CHLORIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CASE REPORT; DIARRHEA; DRUG WITHDRAWAL; FEMALE; GENE; GITELMAN SYNDROME; HUMAN; HYPOCALCIURIA; HYPOKALEMIA; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; METABOLIC ALKALOSIS; PLASMA RENIN ACTIVITY; POINT MUTATION; POTASSIUM BLOOD LEVEL; SEQUENCE ANALYSIS; SLC12A3 GENE; SODIUM BLOOD LEVEL;

EID: 84855216519     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.5723     Document Type: Article

References (18)

1. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24-30, 1996.
2. Knoers NV, Levtchenko EN. Gitelman syndrome. Orphanet J Rare Dis 30: 22, 2008.
3. Vargas-Poussou R, Dahan K, Kahila D, et al. Spectrum of mutations in Gitelman syndrome. J Am Soc Nephrol 22: 693-703, 2011.
4. de Gasparo M, Whitebread SE, Preiswerk G, Jeunemaître X, Corvol P, Ménard J. Antialdosterones: incidence and prevention of sexual side effects. J Steroid Biochem 32: 223-227, 1989.
5. Maron BA, Leopold JA. Aldosterone receptor antagonists: effective but often forgotten. Circulation 121: 934-939, 2010.
6. Struthers A, Krum H, Williams GH. A comparison of the aldosterone-blocking agents eplerenone and spironolactone. Clin Cardiol 31: 153-158, 2008.
7. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309-1321, 2003.
8. Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364: 11-21, 2011.
9. Ando K, Ohtsu H, Arakawa Y, et al. Rationale and design of the Eplerenone combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment Effect (EVALUATE) trial: a double-blinded randomized placebocontrolled trial to evaluate the antialbuminuric effects of an aldosterone blocker in hypertensive patients with albuminuria. Hypertens Res 33: 616-621, 2010.
10. Terui K, Shoji M, Yamashiki J, et al. A novel mutation of the thiazide-sensitive sodium chloride cotransporter gene in a Japanese family with Gitelman syndrome. Clin Nephrol 65: 57-60, 2006.
11. De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 13: 1442-1448, 2002.
12. Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 62: 580-584, 2002.
13. Colussi G, Rombolà G, De Ferrari ME, Macaluso M, Minetti L. Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. Am J Nephrol 14: 127-135, 1994.
14. Yamaji M, Tsutamoto T, Kawahara C, et al. Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failure. Am Heart J 160: 915-921, 2010.
15. Swaminathan K, Davies J, George J, Rajendra NS, Morris AD, Struthers AD. Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles. Diabetologia 51: 762-768, 2008.
16. Nakamura A, Shimizu C, Nagai S, et al. Problems in diagnosing atypical Gitelman's syndrome presenting with normomagnesaemia. Clin Endocrinol (Oxf) 72: 272-276, 2010.
17. Morton A. Eplerenone in the treatment of Gitelman's syndrome. Intern Med J 38: 377, 2008.
18. Morton A, Panitz B, Bush A. Eplerenone for Gitelman syndrome in pregnancy. Nephrology (Carlton) 16: 349, 2011.